Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
8.10
+0.15 (1.89%)
At close: Dec 20, 2024, 4:00 PM
7.78
-0.32 (-4.01%)
After-hours: Dec 20, 2024, 7:17 PM EST
Ensysce Biosciences Employees
Ensysce Biosciences had 7 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$631,629
Profits / Employee
-$1,132,443
Market Cap
10.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | 3 | 100.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| China Jo-Jo Drugstores | 1,003 |
| Zhongchao | 142 |
| Jaguar Health | 49 |
| Apollomics | 45 |
| Relmada Therapeutics | 20 |
| Talphera | 15 |
| Kiora Pharmaceuticals | 12 |
| BioRestorative Therapies | 11 |
ENSC News
- 11 days ago - Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product - Accesswire
- 17 days ago - Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR - Accesswire
- 18 days ago - Ensysce Biosciences Announces 1-for-15 Reverse Stock Split - Accesswire
- 25 days ago - Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR Trial - Accesswire
- 5 weeks ago - Ensysce Biosciences Reports Third Quarter 2024 Financial Results - Accesswire
- 6 weeks ago - Ensysce Biosciences Receives Positive Nasdaq Listing Determination - Accesswire
- 2 months ago - Ensysce Biosciences Announces Leadership Team's Participation in the Annual Pain Therapeutics Summit - Accesswire
- 2 months ago - Ensysce Biosciences Provides Shareholder Update, Responds to Recent Shareholder Inquiries - Accesswire